Literature DB >> 17913690

3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability.

Michal Harel1, Boris Brumshtein, Ran Meged, Hay Dvir, Raimond B G Ravelli, Andrew McCarthy, Lilly Toker, Israel Silman, Joel L Sussman.   

Abstract

Serum paraoxonases (PONs) exhibit a wide range of physiologically important hydrolytic activities, including drug metabolism and detoxification of nerve gases. PON1 and PON3 reside on high-density lipoprotein (HDL) (the "good cholesterol"), and are involved in the alleviation of atherosclerosis. Members of the PON family have been identified not only in mammals and other vertebrates, but also in invertebrates. We earlier described the first crystal structure of a PON family member, a directly-evolved variant of PON1, at 2.2 A resolution. PON1 is a 6-bladed beta-propeller with a unique active-site lid which is also involved in binding to HDL. The 3-D structure, taken together with directed evolution studies, permitted analysis of mutations which enhanced the stability, solubility and crystallizability of this PON1 variant. The structure permits a detailed description of PON1's active site and suggests possible mechanisms for its catalytic activity on certain substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913690     DOI: 10.2478/v10004-007-0028-0

Source DB:  PubMed          Journal:  Arh Hig Rada Toksikol        ISSN: 0004-1254            Impact factor:   1.948


  9 in total

Review 1.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

2.  Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Authors:  Richard C Stevens; Stephanie M Suzuki; Toby B Cole; Sarah S Park; Rebecca J Richter; Clement E Furlong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

Review 3.  Catalytic mechanisms for phosphotriesterases.

Authors:  Andrew N Bigley; Frank M Raushel
Journal:  Biochim Biophys Acta       Date:  2012-04-26

Review 4.  Quorum quenching revisited--from signal decays to signalling confusion.

Authors:  Kar-Wai Hong; Chong-Lek Koh; Choon-Kook Sam; Wai-Fong Yin; Kok-Gan Chan
Journal:  Sensors (Basel)       Date:  2012-04-10       Impact factor: 3.576

5.  VX hydrolysis by human serum paraoxonase 1: a comparison of experimental and computational results.

Authors:  Matthew W Peterson; Steven Z Fairchild; Tamara C Otto; Mojdeh Mohtashemi; Douglas M Cerasoli; Wenling E Chang
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

Review 6.  Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  ScientificWorldJournal       Date:  2014-10-20

Review 7.  Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders.

Authors:  Maria João Meneses; Regina Silvestre; Inês Sousa-Lima; Maria Paula Macedo
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

8.  Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.

Authors:  Alicja E Grzegorzewska; Paulina Adamska; Ewa Iwańczyk-Skalska; Kamila Ostromecka; Leszek Niepolski; Wojciech Marcinkowski; Adrianna Mostowska; Wojciech Warchoł; Czesław Żaba; Paweł P Jagodziński
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

9.  Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.

Authors:  Asefesadat Emami; Mohamadhasan Tajadini; Mehrdad Zeinalian; Mahtab Keshvari; Sedigheh Asgary
Journal:  Interv Med Appl Sci       Date:  2018-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.